# Safety Study of Elidel (Pimecrolimus) 1% Cream to Treat Netherton Syndrome

> **NCT00208026** · PHASE1,PHASE2 · COMPLETED · sponsor: **Children's Hospital of Philadelphia** · enrollment: 3 (actual)

## Conditions studied

- Netherton Syndrome

## Interventions

- **DRUG:** Pimecrolimus 1% Cream

## Key facts

- **NCT ID:** NCT00208026
- **Lead sponsor:** Children's Hospital of Philadelphia
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2019-08-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00208026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00208026, "Safety Study of Elidel (Pimecrolimus) 1% Cream to Treat Netherton Syndrome". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00208026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*